Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy of Nimacimab in Patients With Diabetic Gastroparesis

NCT03900325 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Gastroparesis

Interventions

DRUG: Nimacimab
DRUG: Placebo

Sponsor

Bird Rock Bio, Inc.